SEC Form D · Amendment · filed May 28, 2020
Nautilus Biotechnology, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Matthew Posard · San Carlos, CADirectorAshley Thompson · Chicago, ILDirectorMatt Mulherin · Rogers, ARDirectorStuart Nagae · San Carlos, CADirectorTrinda Blackmore · Grand Cayman, Cayman IslandsDirectorTerry Knoploh · Rogers, ARDirectorMeagan Bowman · Rogers, ARExec · DirectorFarzad Nazem · San Carlos, CADirectorGuillermo Freile · Chicago, ILDirectorParag Mallick · San Carlos, CADirectorRichard Jacinto Ii · RICHMOND, British Columbia, CanadaDirectorVijay Pande · San Carlos, CADirectorTodd Asmuth · New York, NYExec · DirectorSam Mcbride · Chicago, ILDirectorMatthew A. Mccall · Conway, SCDirectorSujal Patel · San Carlos, CAExec · DirectorJay C. Hoag · Menlo Park, CADirectorKhang Ting · HONG KONG, Hong KongDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗